Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Frontiers in Bioscience-LandmarkOpen Access

Clinical, Immunological, and Vesicular Markers in Sarcopenia and Presarcopenia

View Full Paper
Ask AI
Bookmark
Share

Authors

ЛШЛ. М. ШуликоDSDmitry A. SvarovskyЛСЛ. В. Спирина

Discussion

Loading...

Member takes

Overview

Prospective cohort study evaluates sarcopenia through clinical, immunological, and vesicular markers, suggesting new avenues for diagnosis.

Key Points

  • Sarcopenia shows significant markers of chronic inflammation and metabolic disturbance, highlighting its multifactorial nature.
  • Principal component analysis identified key functional marker clusters linked to muscle degeneration and inflammation.
  • Using flow cytometry, immune cell subsets were characterized, emphasizing their role in disease progression.
  • Integrating multiple assessment methods can enhance diagnostic reliability and inform future targeted therapies.

Cite This Study

Шулико et al. (2025) studied this question.

synapsesocial.com/papers/68c239e5b210217d6477ebachttps://doi.org/10.31083/fbl42063
View Full Paper
Ask AI
Bookmark
Share